ÂÜÀòÂÒÂ×

Martin Farlow

Scientific Advisor at Cerecin

Dr. Farlow is Professor, Department of Neurology at Indiana Alzheimer Disease Center. He has been involved in research and clinical care of patients with neurodegenerative diseases, such as Alzheimer's disease (AD) and other dementing conditions, for almost 30 years. He has published in both clinical and basic science areas of AD and related dementias with emphasis on investigational drug trials, molecular genetics, and biological markers for AD. He was the Principal Investigator for the described second family in the world with mutation-associated Alzheimer's disease and is co-holder for the first successful animal model for Alzheimer's disease (the PD-APP Mouse). He is Associate Director of the Indiana Alzheimer's Disease Center and Associate Leader Clinical Core of the Indiana ADC. He serves on and Chairs numerous Data Safety Monitoring Boards and Advisory Boards to the industry. He is a frequent lecturer locally and nationally. He is the Principal Investigator of the Indiana site of the AD Cooperative Study Unit investigating novel treatments of AD and the Alzheimer Disease Neuroimaging Initiative. He is Co-PI for DISCOVER study and is Principal Investigator for of the Indiana Site for the Multi-Center Development of A Novel Diagnostic Test for Alzheimer's Disease.